Xenon Pharmaceuticals Inc
Research Xenon Pharmaceuticals Inc (XENE) on Bullrun: market cap USD 5.81B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerXENE
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 5.81B
- Financial periodFY2025
- RevenueUSD 7.50M
- Net income-USD 345.91M
- Free cash flow-USD 279.92M
Valuation Snapshot
latest market cap is USD 5.81B.
About Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders.
Frequently asked questions
What is Xenon Pharmaceuticals Inc's market cap?
Xenon Pharmaceuticals Inc's market capitalization is USD 5.81B.
What does Xenon Pharmaceuticals Inc do?
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders.